New study aims to keep men with Low-Risk prostate cancer off the operating table

NCT ID NCT05424783

Recruiting now Knowledge-focused Sponsor: Northwestern University Source: ClinicalTrials.gov ↗

First seen Apr 28, 2026 · Last updated May 23, 2026 · Updated 2 times

Summary

This study enrolls 222 men with low- to intermediate-risk prostate cancer to see if combining MRI scans and a genetic test (GPS) helps them stick with active surveillance—monitoring the cancer instead of treating it right away. The goal is to find out whether one or both tests improve safety and reduce unnecessary biopsies or treatments. Researchers will also ask participants what factors most influence their treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Northwestern University
ACTIVE_NOT_RECRUITING

Chicago, Illinois, 60611, United States
University of Illinois at Chicago
RECRUITING

Chicago, Illinois, 60612, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PROSTATE CANCER